| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |